Lung phosphodiesterase isoenzymes

Agents Actions Suppl. 1993:43:35-49. doi: 10.1007/978-3-0348-7324-6_4.

Abstract

The distinct phosphodiesterase isoenzyme activities in guinea-pig lung were identified and characterised. We demonstrate that protein kinase A catalyses the activation of lung Type V cyclic GMP phosphodiesterase. This occurs via a marked change in the Vmax for cyclic GMP hydrolysis. The sensitivity of the activated PDE to inhibition by zaprinast is also markedly reduced (zaprinast inhibits in PDE activity via a mixed mechanism). We suggest that activation of the PDE by protein kinase A involves a mechanism that leads to alteration in the regulatory action of a non-catalytic cyclic GMP binding site.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • Animals
  • Catalysis
  • Enzyme Activation
  • Guinea Pigs
  • Isoenzymes / analysis*
  • Lung / enzymology*
  • Muscle, Smooth / drug effects
  • Perfusion
  • Phosphoric Diester Hydrolases / analysis*
  • Purinones / pharmacology
  • Pyrazines / pharmacology

Substances

  • Isoenzymes
  • Purinones
  • Pyrazines
  • 5-(4-acetamidophenyl)pyrazin-2(1H)-one
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • zaprinast